ReviewCancer2025
Assessing tolerability of cancer therapeutics: A regulatory perspective from the FDA Oncology Center of Excellence.
Vishal Bhatnagar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it